| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 17,855,970 | 19,132,379 | 15,190,961 | | Cost of Revenue | 2,512,040 | 2,906,351 | 1,814,797 | | | Gross Profit | 15,343,930 | 16,226,028 | 13,376,164 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 7,264,687 | 7,939,773 | 6,967,193 | | Non Recurring | 945,340 | 138,237 |
-
| | Others | 5,101,040 | 2,636,502 | 1,476,438 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 2,032,863 | 5,511,516 | 4,932,533 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 2,032,863 | 5,511,516 | 4,932,533 | | Interest Expense | 1,451,244 | 1,641,960 | 1,279,802 | | Income Before Tax | 581,619 | 3,869,556 | 3,652,731 | | Income Tax Expense | 497,102 | 1,277,837 | 1,238,238 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 84,517 | 2,591,719 | 2,414,493 | | | Non-recurring Events | | Discontinued Operations | (130,515) | (1,021,387) |
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (45,998) | 1,570,332 | 2,414,493 | | Preferred Stock And Other Adjustments | (32,723) |
-
|
-
| | | Net Income Applicable To Common Shares | ($78,721) | $1,570,332 | $2,414,493 |
|
0.16% Nasdaq 0.00%
Income Statement
